Tharimmune, Inc. Announces Pricing of $55 Million Underwritten Registered Offering

Core Viewpoint - Tharimmune, Inc. has announced a $55 million registered offering to support its digital asset treasury strategy leveraging the Canton Network, which aims to digitize traditional financial markets [1][2]. Group 1: Offering Details - The offering includes the issuance of 1,800,000 shares of common stock at a price of $2.92 per share and pre-funded warrants to purchase up to 17,000,000 shares at a price of $2.9199 per warrant [2]. - The offering is expected to close on or about January 21, 2026, pending customary closing conditions [2]. Group 2: Company Background - Tharimmune, Inc. is the first publicly traded company to utilize Canton Coin and support the Canton Network, focusing on institutional blockchain adoption and the digitization of financial markets [6]. - The company also engages in clinical-stage biotech research and development [6]. Group 3: Underwriting and Registration - Clear Street is acting as the sole bookrunner for the offering [3]. - The securities are being offered under a shelf registration statement filed with the SEC on January 9, 2026, which became effective on January 16, 2026 [4].